Display options
Cite
Sifianou P, Thanou V, Karga H. Metabolic and hormonal effects of antenatal betamethasone after 35 weeks of gestation. J Pediatr Pharmacol Ther. 2015;20(2):138-43doi: 10.5863/1551-6776-20.2.138.
Sifianou, P., Thanou, V., & Karga, H. (2015). Metabolic and hormonal effects of antenatal betamethasone after 35 weeks of gestation. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG, 20(2), 138-43. https://doi.org/10.5863/1551-6776-20.2.138
Sifianou, Popi, et al. "Metabolic and hormonal effects of antenatal betamethasone after 35 weeks of gestation." The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG vol. 20,2 (2015): 138-43. doi: https://doi.org/10.5863/1551-6776-20.2.138
Sifianou P, Thanou V, Karga H. Metabolic and hormonal effects of antenatal betamethasone after 35 weeks of gestation. J Pediatr Pharmacol Ther. 2015 Mar-Apr;20(2):138-43. doi: 10.5863/1551-6776-20.2.138. PMID: 25964731; PMCID: PMC4418681.
Copy Download .nbib Format: NLM
Share it on

J Pediatr Pharmacol Ther. 2015 Mar-Apr;20(2):138-43. doi: 10.5863/1551-6776-20.2.138.

Metabolic and hormonal effects of antenatal betamethasone after 35 weeks of gestation.

The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG

Popi Sifianou, Voula Thanou, Helen Karga

Affiliations

  1. Department of Neonatology, General and Maternity Hospital Elena Venizelou, Athens, Greece.
  2. Second Division of Endocrinology and Metabolism, Alexandra Hospital, Athens, Greece.

PMID: 25964731 PMCID: PMC4418681 DOI: 10.5863/1551-6776-20.2.138

Abstract

BACKGROUND: Antenatal corticosteroid therapy recently has been considered for term and near-term infants, in addition to preterm infants, delivered by elective cesarean section, with the aim of preventing an adverse respiratory outcome.

OBJECTIVES: The objective of this study was to investigate hormonal and metabolic effects of antenatal betamethasone when administered to term fetuses.

METHODS: Cord blood levels of cortisol, C-peptide, insulin-like growth factor I and its binding protein 3, and 5 more analytes including glucose were measured in singleton newborns of over 35 weeks of gestational age. In anticipation of a cesarean delivery, the mother was either treated or not treated with 12 mg of intramuscularly administered antenatal betamethasone approximately 24 hours prior to birth. Babies of comparable gestational age, sex, and nutritional status who were not treated antenatally served as controls.

RESULTS: Cord serum cortisol levels of the betamethasone-treated fetuses were suppressed to <10% of that of untreated controls (median levels of 11.6 nmol/L vs. 138.2 nmol/L, respectively), and their C-peptide and glucose levels were significantly higher (2.85 mcg/L vs. 1.19 mcg/L, respectively, p < 0.0001; and 62.5 mg/dL vs. 56.0 mg/dL, respectively, p = 0.01).

CONCLUSIONS: Prophylactic betamethasone therapy causes immediate hormonal alterations, which might interfere with the metabolic adaptation of the newborn. This issue deserves thorough investigation.

Keywords: antenatal corticosteroids; betamethasone; hyperinsulinemia; hypoglycemia; neonate

References

  1. Biol Neonate. 1986;50(5):237-58 - PubMed
  2. Pediatr Res. 2007 Sep;62(3):295-300 - PubMed
  3. Pediatrics. 1972 Oct;50(4):515-25 - PubMed
  4. BMJ. 2008 Jan 12;336(7635):85-7 - PubMed
  5. Early Hum Dev. 2011 Aug;87(8):549-54 - PubMed
  6. Am J Obstet Gynecol. 2009 Dec;201(6):611.e1-7 - PubMed
  7. JAMA. 1995 Feb 1;273(5):413-8 - PubMed
  8. Neonatology. 2013;103(4):353-68 - PubMed
  9. Am J Obstet Gynecol. 1981 Oct 1;141(3):276-87 - PubMed
  10. BMJ. 2011 Apr 12;342:d1696 - PubMed
  11. Acta Obstet Gynecol Scand. 2012 Dec;91(12):1469-73 - PubMed
  12. Diabetologia. 1987 Jun;30(6):394-6 - PubMed
  13. Clin Biochem. 2003 Mar;36(2):109-12 - PubMed
  14. Obstet Gynecol. 2012 May;119(5):909-16 - PubMed
  15. Endocr Rev. 2009 Dec;30(7):753-89 - PubMed
  16. Semin Fetal Neonatal Med. 2009 Jun;14(3):157-63 - PubMed
  17. Acta Paediatr. 2007 May;96(5):664-8 - PubMed
  18. Acta Paediatr. 2006 Dec;95(12):1620-4 - PubMed
  19. BMJ. 2005 Sep 24;331(7518):662 - PubMed
  20. Placenta. 2013 May;34(5):407-15 - PubMed
  21. Cochrane Database Syst Rev. 2006 Jul 19;(3):CD004454 - PubMed
  22. J Clin Endocrinol Metab. 2012 Oct;97(10):3538-44 - PubMed
  23. J Clin Endocrinol Metab. 2012 Oct;97(10):3457-9 - PubMed
  24. Growth Horm IGF Res. 2006 Aug;16(4):267-75 - PubMed
  25. Pediatr Clin North Am. 1994 Oct;41(5):875-91 - PubMed
  26. J Biol Chem. 1984 Dec 25;259(24):15242-51 - PubMed
  27. Am J Obstet Gynecol. 2012 Dec;207(6):446-54 - PubMed
  28. Diabetes Care. 1980 May-Jun;3(3):425-9 - PubMed
  29. J Clin Endocrinol Metab. 2005 Jun;90(6):3449-53 - PubMed

Publication Types